AXON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Axon Enterprise Inc (AXON) is not a strong buy for a beginner, long-term investor at this moment. While the company has strong growth potential and positive catalysts, the technical indicators are bearish, and the recent financial performance shows significant declines in net income and EPS. The stock is currently trading below key support levels, and there are no strong proprietary trading signals to suggest an immediate entry point. Given the investor's preference for long-term growth, it may be better to wait for a more favorable technical setup or improved financial performance before investing.
The technical indicators for AXON are bearish. The MACD histogram is negative and expanding downward, RSI is neutral but leaning towards oversold, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its key support level (S1: 455.648), with a pivot at 482.935. The stock has a 70% chance of declining further in the next day, week, and month.
Hedge funds are significantly increasing their positions in AXON, with a 1255.57% increase in buying activity last quarter.
Analysts maintain a positive long-term outlook, with multiple firms highlighting Axon's strong growth potential in AI, international markets, and public safety applications.
Axon achieved 39% YoY revenue growth in Q4 2025 and expects to reach $6 billion in annual revenue by 2028, supported by strong future contracted bookings exceeding $14 billion.
Recent financial performance shows a significant decline in net income (-97.97% YoY) and EPS (-98.19% YoY), raising concerns about profitability.
The broader market sentiment is negative, with the S&P 500 down 1.79%.
Technical indicators are bearish, and the stock is trading below key support levels, suggesting potential for further downside.
Analysts have lowered price targets across the board, reflecting sector-wide re-rating and negative sentiment.
In Q4 2025, Axon reported a 38.53% YoY increase in revenue to $797 million, driven by strong software revenue growth (+40%). However, net income dropped significantly by 97.97% YoY to $2.75 million, and EPS fell by 98.19% YoY to $0.03. Gross margin also declined slightly to 57.9%, down 3.71% YoY, indicating pressure on profitability despite revenue growth.
Analysts maintain a generally positive outlook on Axon, with most firms rating the stock as Buy or Overweight. However, price targets have been lowered across the board due to sector-wide re-rating and negative sentiment. The average price target remains significantly above the current price, reflecting long-term growth potential despite short-term challenges.
